Loading...
Market
What will be the impact on GenScript's stock price by January 31, 2025?
4
China•FBI•ODNI•Chinese•GenScript•Chinese Communist Party•CCP•John Moolenaar•Raja Krishnamoorthi•Legend Biotech
Resolution / Starting Odds
Increase by 10% or more • 25%
Decrease by 10% or more • 25%
Increase or decrease less than 10% • 25%
No significant change • 25%
Stock market performance data
Story
House China Panel Seeks FBI, ODNI Briefing on GenScript's CCP Links
May 31, 2024, 07:02 PM
The U.S. House of Representatives committee on China has requested a briefing from the FBI and the Office of the Director of National Intelligence (ODNI) on the activities of Chinese biotech firm GenScript and its connections to the Chinese Communist Party (CCP). The committee, led by Chairman Rep. John Moolenaar and Ranking Member Rep. Raja Krishnamoorthi, is particularly concerned about GenScript's role in establishing CCP-controlled chokepoints in critical areas of the biotechnology industry. This request marks an expansion of the committee's focus from contract research organizations (CROs) and national security to include therapeutics developers and commercial competitiveness, including Legend Biotech.
View original story
Similar markets
Decrease more than 5% • 25%
Decrease up to 5% • 25%
Increase up to 5% • 25%
Increase more than 5% • 25%
Increase over 20% • 25%
Increase 10-20% • 25%
Decrease 10-20% • 25%
Decrease over 20% • 25%
Increase by 10% or more • 25%
Increase by less than 10% • 25%
No significant change • 25%
Decrease • 25%
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
Ipsen stock outperforms • 33%
Genfit stock outperforms • 33%
Both perform equally • 34%
Increases significantly • 25%
Stays the same • 25%
Decreases slightly • 25%
Decreases significantly • 25%
Increase by over 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
No significant change or decrease • 25%
Stock Price Drops by 10% or More • 33%
Stock Price Remains Stable (±10%) • 33%
Stock Price Increases by 10% or More • 34%
Increase by more than 20% • 33%
Increase by 0-20% • 33%
Decrease • 33%
Significantly higher (>10%) • 25%
Moderately higher (5-10%) • 25%
Lower or unchanged (<5%) • 25%
Significantly lower (>10%) • 25%
Increase by over 50% • 25%
Increase by less than 50% • 25%
Decrease • 25%
Remain stable (±10%) • 25%